The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee

E Campo, ES Jaffe, JR Cook… - Blood, The Journal …, 2022 - ashpublications.org
Since the publication of the Revised European-American Classification of Lymphoid
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …

Classification and diagnostic evaluation of nodal T-and NK-cell lymphomas

AL Feldman, C Laurent, M Narbaitz, S Nakamura… - Virchows Archiv, 2023 - Springer
Nodal T-and NK-cell lymphomas are among the most frequent T-cell malignancies and most
subtypes have aggressive clinical behavior. Evolving understanding of the biology and …

Genomic profiling for clinical decision making in lymphoid neoplasms

L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …

Novel targeted therapies of T cell lymphomas

K Iżykowska, K Rassek, D Korsak… - Journal of Hematology & …, 2020 - Springer
T cell lymphomas (TCL) comprise a heterogeneous group of non-Hodgkin lymphomas
(NHL) that often present at an advanced stage at the time of diagnosis and that most …

Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: results of the Ro-CHOP phase III study (conducted by LYSA)

E Bachy, V Camus, C Thieblemont, D Sibon… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Romidepsin, a histone deacetylase inhibitor, has demonstrated activity in
relapsed or refractory peripheral T-cell lymphoma (PTCL) as a single agent …

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

RH Advani, T Skrypets, M Civallero… - Blood, The Journal …, 2021 - ashpublications.org
Angioimmunoblastic T-cell lymphoma (AITL) is a unique subtype of peripheral T-cell
lymphoma (PTCL) with distinct clinicopathologic features and poor prognosis. We performed …

T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology

SM Horwitz, S Ansell, WZ Ai, J Barnes, SK Barta… - Journal of the National …, 2022 - jnccn.org
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative
disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas …

A comparison of the International Consensus and 5th WHO classifications of T‐cell lymphomas and histiocytic/dendritic cell tumours

B Falini, S Lazzi, S Pileri - British Journal of Haematology, 2023 - Wiley Online Library
Since the publication in 2017 of the revised 4th Edition of the World Health Organization
(WHO) classification of haematolymphoid tumours, here referred to as WHO‐HAEM4 …

[HTML][HTML] Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up

F Vega, C Amador, A Chadburn, ED Hsi, G Slack… - Modern Pathology, 2022 - Elsevier
Peripheral T-cell lymphomas are a heterogeneous, and usually aggressive, group of mature
T-cell neoplasms with overlapping clinical, morphologic and immunologic features. A large …

Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas

SE Yoon, J Cho, YJ Kim, YH Ko, WY Park… - … hematology & oncology, 2021 - Springer
Abstract Background The 2016 World Health Organization (WHO) classification introduced
nodal lymphomas of T follicular helper (Tfh) cell origin, such as angioimmunoblastic T-cell …